159 related articles for article (PubMed ID: 18275432)
1. IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14).
Feyler S; O'Connor SJ; Rawstron AC; Subash C; Ross FM; Pratt G; Drayson MT; Ashcroft J; Cook G; Owen RG
Br J Haematol; 2008 Mar; 140(5):547-51. PubMed ID: 18275432
[TBL] [Abstract][Full Text] [Related]
2. [Close correlations between CD20 expression, a small mature plasma cell morphology and t(11 ; 14) in multiple myeloma].
Matsuda I; Mori Y; Nakagawa Y; Sawanobori M; Uemura N; Suzuki K
Rinsho Ketsueki; 2005 Dec; 46(12):1293-7. PubMed ID: 16447802
[TBL] [Abstract][Full Text] [Related]
3. IgM multiple myeloma: pathologic evaluation of a rare entity.
King RL; Howard MT; Hodnefield JM; Morice WG
Am J Clin Pathol; 2013 Oct; 140(4):519-24. PubMed ID: 24045549
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).
Pruneri G; Fabris S; Baldini L; Carboni N; Zagano S; Colombi MA; Ciceri G; Lombardi L; Rocchi M; Buffa R; Maiolo AT; Neri A
Am J Pathol; 2000 May; 156(5):1505-13. PubMed ID: 10793062
[TBL] [Abstract][Full Text] [Related]
5. A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report.
Gozzetti A; Cerase A; Crupi R; Raspadori D; Defina M; Bocchia M; Lauria F
Leuk Res; 2011 Nov; 35(11):e206-8. PubMed ID: 21767877
[No Abstract] [Full Text] [Related]
6. Mott cells in CD20-positive myeloma.
Ramasamy K; Ladon D; Salisbury J; Ireland R
Br J Haematol; 2011 Feb; 152(4):366. PubMed ID: 21265822
[No Abstract] [Full Text] [Related]
7. Immunohistochemical analysis identifies two cyclin D1+ subsets of plasma cell myeloma, each associated with favorable survival.
Cook JR; Hsi ED; Worley S; Tubbs RR; Hussein M
Am J Clin Pathol; 2006 Apr; 125(4):615-24. PubMed ID: 16627271
[TBL] [Abstract][Full Text] [Related]
8. Genetic abnormalities and patterns of antigenic expression in multiple myeloma.
Mateo G; Castellanos M; Rasillo A; Gutiérrez NC; Montalbán MA; Martín ML; Hernández JM; López-Berges MC; Montejano L; Bladé J; Mateos MV; Sureda A; de la Rubia J; Díaz-Mediavilla J; Pandiella A; Lahuerta JJ; Orfao A; San Miguel JF
Clin Cancer Res; 2005 May; 11(10):3661-7. PubMed ID: 15897562
[TBL] [Abstract][Full Text] [Related]
9. CD20-negative low-grade B cell lymphoma showing immunophenotypic and genotypic features resembling plasma cell myeloma.
Tabata R; Yasumizu R; Tabata C; Kojima M
Pathol Res Pract; 2013 Jul; 209(7):459-62. PubMed ID: 23707547
[TBL] [Abstract][Full Text] [Related]
10. Frequency and distribution of trisomy 11 in multiple myeloma patients: relation with overexpression of CCND1 and t(11;14).
Guglielmelli T; Giugliano E; Cappia S; Papotti M; Saglio G
Cancer Genet Cytogenet; 2007 Feb; 173(1):51-6. PubMed ID: 17284370
[TBL] [Abstract][Full Text] [Related]
11. Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14).
Hundemer M; Klein U; Hose D; Raab MS; Cremer FW; Jauch A; Benner A; Heiss C; Moos M; Ho AD; Goldschmidt H
Bone Marrow Transplant; 2007 Dec; 40(11):1033-7. PubMed ID: 17891186
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic Study and Analysis of Protein Expression in Plasma Cell Myeloma with t(11;14)(q13;q32): Absence of BCL6 and SOX11, and Infrequent Expression of CD20 and PAX5.
Yokoi S; Sakai H; Uchida A; Uemura Y; Sato K; Tsuruoka Y; Nishio Y; Matsunawa M; Suzuki Y; Isobe Y; Kato M; Inoue Y; Hoshikawa M; Miura I
J Clin Exp Hematop; 2015; 55(3):137-43. PubMed ID: 26763361
[TBL] [Abstract][Full Text] [Related]
13. t(11;14) multiple myeloma: a subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome.
An G; Xu Y; Shi L; Zou D; Deng S; Sui W; Xie Z; Hao M; Chang H; Qiu L
Leuk Res; 2013 Oct; 37(10):1251-7. PubMed ID: 23927993
[TBL] [Abstract][Full Text] [Related]
14. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
[TBL] [Abstract][Full Text] [Related]
15. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
[TBL] [Abstract][Full Text] [Related]
16. [Detection of deletion of the long arm of chromosome 13 and translocation of immunoglobulin heavy chain gene by interphase fluorescence in situ hybridization in patients with multiple myeloma].
Sun WL; Wu YJ; Li H; Wang X; Zhuang JL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):485-90. PubMed ID: 18795626
[TBL] [Abstract][Full Text] [Related]
17. Absence of both CD56 and CD117 expression on malignant plasma cells is related with a poor prognosis in patients with newly diagnosed multiple myeloma.
Pan Y; Wang H; Tao Q; Zhang C; Yang D; Qin H; Xiong S; Tao L; Wu F; Zhang J; Zhai Z
Leuk Res; 2016 Jan; 40():77-82. PubMed ID: 26597998
[TBL] [Abstract][Full Text] [Related]
18. Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma.
Moreau P; Robillard N; Avet-Loiseau H; Pineau D; Morineau N; Milpied N; Harousseau JL; Bataille R
Haematologica; 2004 May; 89(5):547-51. PubMed ID: 15136217
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.
Lin P; Owens R; Tricot G; Wilson CS
Am J Clin Pathol; 2004 Apr; 121(4):482-8. PubMed ID: 15080299
[TBL] [Abstract][Full Text] [Related]
20. CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis.
Bataille R; Pellat-Deceunynck C; Robillard N; Avet-Loiseau H; Harousseau JL; Moreau P
Leuk Res; 2008 Mar; 32(3):379-82. PubMed ID: 17767956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
